Primary practice
Find Dr. Toor's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Toor practices at Elkhart General Hospital in Elkhart, Indiana, part of Beacon Health System.
Dr. Toor's NPI, 1477868180, was assigned on August 18, 2010. Dr. Toor holds Indiana license 01072276A.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Toor's primary practice is Elkhart General Hospital, at 600 E Blvd, Elkhart, IN 46514 in Elkhart County. The practice phone is (574) 294-2621.
Source: Dmand AI Affiliation Data
Dr. Toor's primary practice is Elkhart General Hospital in Elkhart, Indiana, part of Beacon Health System. Dr. Toor is also affiliated with Memorial Hospital of South Bend. The medical group on file is Beacon Medical Group Schwartz-Wiekamp. Dmand AI also links Dr. Toor to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Toor practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Elkhart General Hospital | Available with a free account |
| +4 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Beacon Health System and 6.2K+ hospitals, with verified contacts in the same login.
Hematology and oncology is Dr. Toor's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Toor's licenses on file in 3 states: Indiana, Illinois and Michigan.
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
CMS data shows 799 Medicare services from Dr. Toor across 7 procedure codes in 2024, for 212 Medicare patients. Medicare paid $80,058 for them.
Medians across 215 hematologists and oncologists in Indiana with Dmand AI profiles that report each measure.
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Toor?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Toor and other hematologists and oncologists in Indiana.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
CMS counts 212 Medicare patients who saw Dr. Toor in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Toor's median patient age at 73, with 58% women.
Share of Medicare patients with each condition. A patient can have several.
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Median age 73
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
In 2024, Dr. Toor wrote 1,030 Medicare Part D claims for 199 patients. 84% of them were for generic drugs. CMS names the drug for 815 of them, across 26 drugs with 11 or more claims each, at $617,455 in total drug cost. In 2023, CMS named 759 claims across 25 drugs.
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Drugs named by CMS: 26 in 2024, 25 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Toor accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dmand AI links Dr. Toor to 10 clinical trials, 6 of them phase 2 studies. 10 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Cystadenocarcinoma, Mucinous. National Cancer Institute (NCI) sponsors the most, 10.
Conditions in Dr. Toor's trials
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
CMS Open Payments shows 84 general payments to Dr. Toor from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Astellas Pharma US Inc paid the most, $246.
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
Dr. Omer Muhammad Toor's NPI number is 1477868180. It was assigned on August 18, 2010, and it is active in the NPI Registry.
Dr. Omer Muhammad Toor is a hematologist and oncologist in Elkhart, Indiana. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Dr. Toor practices at 600 E Blvd, Elkhart, IN 46514. Dr. Toor's primary practice is Elkhart General Hospital in Elkhart, Indiana, part of Beacon Health System. Dmand AI also links Dr. Toor to 1 hospital, 2 group practices and clinics and 2 medical groups.
The practice phone on file for Dr. Toor is (574) 294-2621.
Dr. Toor holds Indiana license 01072276A, one of the licenses on file in 3 states.
Dmand AI has state licenses on file for Dr. Toor in Indiana, Illinois and Michigan.
Dr. Toor practices at Elkhart General Hospital in Elkhart, Indiana. Dr. Toor is also affiliated with Memorial Hospital of South Bend. Dmand AI links Dr. Toor to 1 more hospital.
Dr. Toor is linked to Beacon Medical Group Schwartz-Wiekamp. Dmand AI links Dr. Toor to 2 more medical groups.
Yes. CMS data shows Dr. Toor billed Medicare for 799 services in 2024, and Dr. Toor accepts Medicare assignment.
CMS counts 212 Medicare patients who saw Dr. Toor in 2024, with an average age of 73.
In 2024, Dr. Toor's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and office visit, established patient (99213).
In 2024 Medicare Part D data, Dr. Toor's most prescribed drugs by claims were Ondansetron HCl, Anastrozole and Dexamethasone.
CMS Open Payments shows $2,422 in general payments to Dr. Toor from 32 companies from 2016 to 2025. The largest total came from Astellas Pharma US Inc.
Dr. Toor graduated from medical school in 2005, 21 years ago.
Dr. Toor has worked on 10 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in Indiana by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.